Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Attacking the flank: targeting new pathways in SBMA

Nature Medicine volume 18, pages 1461–1463 (2012)Cite this article

Subjects

Androgen withdrawal–based therapeutic strategies for spinal and bulbar muscular atrophy (SBMA) have shown limited benefit in clinical trials, and therapies for this disease still remain a considerable challenge. The finding that a class of migraine medications, the triptans, improve disease in a mouse model of SBMA suggests a new route for future investigations into SBMA therapies (pages 1531–1538).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Targeting CGRP1 upregulation in SBMA using naratriptan.

References

  1. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. Nature 352, 77–79 (1991).

    Article  CAS  Google Scholar 

  2. Kennedy, W.R., Alter, M. & Sung, J.H. Neurology 18, 671–680 (1968).

    Article  CAS  Google Scholar 

  3. Sobue, G. et al. Brain 112, 209–232 (1989).

    Article  Google Scholar 

  4. Chevalier-Larsen, E.S. et al. J. Neurosci. 24, 4778–4786 (2004).

    Article  CAS  Google Scholar 

  5. Katsuno, M. et al. Neuron 35, 843–854 (2002).

    Article  CAS  Google Scholar 

  6. Takeyama, K. et al. Neuron 35, 855–864 (2002).

    Article  CAS  Google Scholar 

  7. Fernández-Rhodes, L.E. et al. Lancet Neurol. 10, 140–147 (2011).

    Article  Google Scholar 

  8. Katsuno, M. et al. Lancet Neurol. 9, 875–884 (2010).

    Article  CAS  Google Scholar 

  9. Rhodes, L.E. et al. Brain 132, 3242–3251 (2009).

    Article  Google Scholar 

  10. Montie, H.L. et al. Hum. Mol. Genet. 18, 1937–1950 (2009).

    Article  CAS  Google Scholar 

  11. Nedelsky, N.B. et al. Neuron 67, 936–952 (2010).

    Article  CAS  Google Scholar 

  12. Orr, C.R. et al. J. Biol. Chem. 285, 35567–35577 (2010).

    Article  CAS  Google Scholar 

  13. Minamiyama, M. et al. Nat. Med. 18, 1531–1538 (2012).

    Article  CAS  Google Scholar 

  14. Ho, T.W., Edvinsson, L. & Goadsby, P.J. Nat. Rev. Neurol. 6, 573–582 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diane E. Merry is in the Department of Biochemistry and Molecular Biology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.,

    Diane E Merry

Authors
  1. Diane E Merry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Diane E Merry.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Merry, D. Attacking the flank: targeting new pathways in SBMA. Nat Med 18, 1461–1463 (2012). https://doi.org/10.1038/nm.2967

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2967

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research